Nonacog beta pegol

N/A

Report date: 2022/05/11 12:43:14

Base Information

Drug NameNonacog beta pegol
Drug Alias NameGlycopegylated Rfix长效凝血因子IX培戈-凝血素-9βnonacogum beta pegolumnonacog beta pegol +[14] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemorrhageHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/05/31
Country/TerritoryBulgariaCanadaUnited States +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk IncNovo Nordisk A/SNovo Nordisk (China)Pharmaceuticals Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsHemorrhageHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD04
Related LinksKEGG